A modified technique for intralesional injection of collagenase Clostridium histolyticum for Peyronie’s disease results in reduced procedural morbidity using a standardized hematoma classification rubric

被引：0
作者：
Arash Amighi
Steven A. Mills
Sriram V. Eleswarapu
Keith V. Regets
Neil Mendhiratta
Jesse N. Mills
机构：
[1] University of California,Department of Urology, David Geffen School of Medicine
[2] Los Angeles,undefined
来源：
World Journal of Urology | 2020年 / 38卷
关键词：
Collagenase ; Peyronie’s disease; Intralesional injection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：293 / 298
页数：5
相关论文
共 131 条
[1]  
Gelbard M(2013)Clinical efficacy, safety and tolerability of collagenase J Urol 190 199-207
[2]  
Goldstein I(2015) for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies J Sex Med 12 248-258
[3]  
Hellstrom WJ(2015)Clinical safety and effectiveness of collagenase BJU Int 116 650-656
[4]  
McMahon CG(2018) injection in patients with Peyronie’s disease: a phase 3 open-label study Urology 119 109-114
[5]  
Smith T(2017)Clinical efficacy of collagenase Urology 104 102-109
[6]  
Tursi J(2017) in the treatment of Peyronie’s disease by subgroup: results from two large, double-blind, randomized, placebo-controlled, phase III studies J Sex Med 14 1430-1437
[7]  
Jones N(2017)Plaque calcification: an important predictor of collagenase Sex Med Rev 5 529-535
[8]  
Kaufman GJ(2017) treatment outcomes for men with Peyronie’s disease Urology 100 125-130
[9]  
Carson CC(2017)Clinical experience with penile traction therapy among men undergoing collagenase BJU Int 120 717-723
[10]  
Levine LA(2018) for Peyronie disease Andrology 6 564-567
12345678910